These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10347245)

  • 1. Molecular determinants of (+)-tubocurarine binding at recombinant 5-hydroxytryptamine3A receptor subunits.
    Hope AG; Belelli D; Mair ID; Lambert JJ; Peters JA
    Mol Pharmacol; 1999 Jun; 55(6):1037-43. PubMed ID: 10347245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological differences and similarities between the native mouse 5-HT3 receptor in N1E-115 cells and a cloned short splice variant of the mouse 5-HT3 receptor expressed in HEK 293 cells.
    Brüss M; Molderings GJ; Bönisch H; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):225-33. PubMed ID: 10543422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of loop F residues in determining differential d-tubocurarine potencies in mouse and human 5-hydroxytryptamine 3A receptors.
    Zhang R; Wen X; Militante J; Hester B; Rhubottom HE; Sun H; Leidenheimer NJ; Yan D; White MM; Machu TK
    Biochemistry; 2007 Feb; 46(5):1194-204. PubMed ID: 17260949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 4'lysine in the putative channel lining domain affects desensitization but not the single-channel conductance of recombinant homomeric 5-HT3A receptors.
    Gunthorpe MJ; Peters JA; Gill CH; Lambert JJ; Lummis SC
    J Physiol; 2000 Jan; 522 Pt 2(Pt 2):187-98. PubMed ID: 10639097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cytoplasmic region determines single-channel conductance in 5-HT3 receptors.
    Kelley SP; Dunlop JI; Kirkness EF; Lambert JJ; Peters JA
    Nature; 2003 Jul; 424(6946):321-4. PubMed ID: 12867984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal domains in mouse and human 5-hydroxytryptamine3A receptors confer partial agonist and antagonist properties to benzylidene analogs of anabaseine.
    Zhang R; White NA; Soti FS; Kem WR; Machu TK
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1276-84. PubMed ID: 16551836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 5-hydroxytryptamine type 3 (5-HT3) receptor reveals a novel determinant of single-channel conductance.
    Peters JA; Kelley SP; Dunlop JI; Kirkness EF; Hales TG; Lambert JJ
    Biochem Soc Trans; 2004 Jun; 32(Pt3):547-52. PubMed ID: 15157181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of 5-HT3 receptor-mediated response and trafficking by activation of protein kinase C.
    Sun H; Hu XQ; Moradel EM; Weight FF; Zhang L
    J Biol Chem; 2003 Sep; 278(36):34150-7. PubMed ID: 12791692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and functional expression of a human 5-hydroxytryptamine type 3AS receptor subunit.
    Belelli D; Balcarek JM; Hope AG; Peters JA; Lambert JJ; Blackburn TP
    Mol Pharmacol; 1995 Dec; 48(6):1054-62. PubMed ID: 8848005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of 5-hydroxytryptamine3A receptor function by phorbol 12-myristate, 13-acetate is mediated by protein kinase C and tyrosine kinase activity.
    Coultrap SJ; Machu TK
    Recept Channels; 2002; 8(2):63-70. PubMed ID: 12448787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a domain affecting agonist potency of meta-chlorophenylbiguanide in 5-HT3 receptors.
    Mochizuki S; Miyake A; Furuichi K
    Eur J Pharmacol; 1999 Mar; 369(1):125-32. PubMed ID: 10204690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Length and amino acid sequence of peptides substituted for the 5-HT3A receptor M3M4 loop may affect channel expression and desensitization.
    McKinnon NK; Bali M; Akabas MH
    PLoS One; 2012; 7(4):e35563. PubMed ID: 22539982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptor.
    Lochner M; Lummis SC
    Biophys J; 2010 Apr; 98(8):1494-502. PubMed ID: 20409468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential composition of 5-hydroxytryptamine3 receptors synthesized in the rat CNS and peripheral nervous system.
    Morales M; Wang SD
    J Neurosci; 2002 Aug; 22(15):6732-41. PubMed ID: 12151552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginine 222 in the pre-transmembrane domain 1 of 5-HT3A receptors links agonist binding to channel gating.
    Hu XQ; Zhang L; Stewart RR; Weight FF
    J Biol Chem; 2003 Nov; 278(47):46583-9. PubMed ID: 12970351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunolabeling of the rat central nervous system with antibodies partially selective of the short form of the 5-HT3 receptor.
    Doucet E; Miquel MC; Nosjean A; Vergé D; Hamon M; Emerit MB
    Neuroscience; 2000; 95(3):881-92. PubMed ID: 10670455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acid residues involved in agonist binding and its linking to channel gating, proximal to transmembrane domain of 5-HT3A receptor for halothane modulation.
    Kim MK; Min KT; Koo BN
    Korean J Anesthesiol; 2009 Jan; 56(1):66-73. PubMed ID: 30625697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5-HT3B subunit is a major determinant of serotonin-receptor function.
    Davies PA; Pistis M; Hanna MC; Peters JA; Lambert JJ; Hales TG; Kirkness EF
    Nature; 1999 Jan; 397(6717):359-63. PubMed ID: 9950429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of a rat 5-hydroxytryptamine type3 receptor subunit (r5-HT3A(b)) expressed in Xenopus laevis oocytes.
    Mair ID; Lambert JJ; Yang J; Dempster J; Peters JA
    Br J Pharmacol; 1998 Aug; 124(8):1667-74. PubMed ID: 9756382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular determinants of picrotoxin inhibition of 5-hydroxytryptamine type 3 receptors.
    Das P; Dillon GH
    J Pharmacol Exp Ther; 2005 Jul; 314(1):320-8. PubMed ID: 15814570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.